Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
M D Caballero, J A Pérez-Simón, A Iriondo, J J Lahuerta, J Sierra, J Marín, M Gandarillas, R Arranz, J Zuazu, V Rubio, A Fernández de Sevilla, E Carreras, J García-Conde, J García-Laraña, C Grande, A Sureda, M J Vidal, J Rifón, C Pérez-Equiza, R Varela, J M Moraleda, J C García Ruíz, C Albó, R Cabrera, J F San Miguel, E Conde
BACKGROUND: The purpose of this study was to analyse the results and prognostic factors influencing overall survival (OS) and disease-free survival (DFS) in 452 patients diagnosed with diffuse large cell lymphomas (DLCL) treated with high-dose therapy (HDT) included in the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL-TAMO) Spanish registry. PATIENTS AND METHODS: At transplantation, median age was 42 years (range 15-73), 146 patients (32%) were transplanted in first complete remission (1st CR), 19% in second CR (2nd CR) and 47% had active disease: sensitive disease in 157 (35%) patients [95 were in first partial remission (1st PR) and 62 in second PR (2nd PR)] and refractory disease in 55 (12%) patients...
January 2003: Annals of Oncology: Official Journal of the European Society for Medical Oncology
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
